Changes in body mass index during chemotherapy are positively associated with height outcome in childhood cancer survivors of acute lymphoblastic leukemia.

When comparing adult height to the height at ALL diagnosis in individuals treated with CHT alone, a decline in height-SDS was documented in previous publications as follows: –0.59 ± 0.86 [ 12 ], –0.49 ± 0.14 [ 26 ], and –0.30 ± 0.14 [ 27 ], although the decline in height-SDS of –0.10 (IQR: –0.49 to 0.16) between at diagnosis and the current visit did not reach statistical significance in our study ( p = 0.075).

also in 111,027 other papers